Austin, TX · Founded 2016 · Privately Held (backing)
Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. Maxwell Biosciences is based in Austin, TX and was founded in 2016. It was valued at $50.9 million at its seed round in Oct 2023, the last priced event on record. It has raised $35.5 million across 1 recorded round; the latest was a $10.9 million early-stage round in Oct 2021.
PMV mark · valuation
$50.9M
Oct 2026
Priced at
its seed round
Oct 2023
Total raised
$35.5M
Last round
Early Stage VC
Oct 2021
Cap table — not yet on record
Maxwell Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Maxwell Biosciences with a free account
·The complete investor list: 30 names
·Watch Maxwell Biosciences: the Monday email on marks, rounds and moves
Where does Maxwell Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Maxwell Biosciences's 1 recorded funding rounds.
